Croda Expands Biopharma Capabilities Through Strategic Partnership
Croda International Plc recently announced a strategic supply partnership with Amino GmbH aimed at strengthening the global availability of high purity amino acids for pharmaceutical formulation and biomanufacturing.
Combining Croda’s deep expertise in smart science and global market reach, with Amino’s advanced capabilities in precision manufacturing of amino acids will enable Croda to deliver even more innovative, high-quality and sustainable solutions that help customers accelerate their product development and achieve greater efficiency.
“This partnership reflects Croda’s strategy, to strengthen our ability to support customers in the fast-evolving biopharma landscape” said Katie Dec, Global Business Director, Croda International Plc. “Amino’s strong reputation and expertise make them an ideal partner as we continue to deliver high-quality, reliable materials needed to bring new therapies to market.”
“The partnership with Croda is both a milestone and a catalyst for Amino’s ambitions in biopharmaceuticals. The combination of Croda’s market reach and our high-purity amino acid production expertise forms a partnership dedicated to meeting specific customer demands,” states Lutz Thomas, Managing Director of Amino GmbH.
This reinforces Croda’s commitment to supplying the highest purity ingredients for pharmaceutical formulation and biomanufacturing and follows on from the recent launches of Virodex™ for viral inactivation and cell lysis, and Super Poloxamer 188 as a shear protectant in cell culture media.
For more information on our latest products: Croda Pharma | Super Refined Polaxamer 188
Croda is a specialty chemicals company that creates high performance ingredients and solutions principally for Consumer Care and Life Sciences markets. Established 100 years ago in 1925 and headquartered in the UK, Croda is a FTSE 100 company with over 5,800 employees across 92 locations in 39 countries. Revenues in 2023 were £1.69bn.
As the name behind some of the world’s most successful brands, we combine our knowledge, passion and entrepreneurial spirit to develop and supply innovative ingredients relied on by industries and consumers around the world. Our smart science is found in products that touch our lives every day from sun protection to life-saving pharmaceuticals and formulations that enhance crop yields.
With a shared Purpose to use Smart science to improve lives, and with around two thirds of its organic raw materials already from bio-based sources, Croda has committed to be the most sustainable supplier of innovative ingredients, becoming Climate, Land and People Positive by 2030 while providing solutions to some of the world’s biggest challenges.
Croda’s Pharma business is a leading partner in the development of excipients and the supply of high purity materials for pharmaceutical formulations and is committed to enabling the next generation of drug delivery systems. The business is focused on empowering biologics drug delivery, through its adjuvant systems, small molecule, protein, and nucleic acid delivery platforms.
Amino GmbH based in Frellstedt, Germany is a manufacturer of high-quality amino acids and related substances focused on pharmaceutical and nutritional applications.
The business portfolio is completed by our innovation platform AminoVation as well as amino acid premixes under the AMixCo brand. To find out more about Amino GmbH visit: www.amino.de.
Total Page Views: 204















